我们的管线
Our Pipeline
| Candidate | Indication | Early Discovery | Pre-clinical | IND | Phase I | Phase II | Phase III |
|---|---|---|---|---|---|---|---|
| SST001/18F-FD4 α-Syn PET tracer 与迈克尔·J·福克斯基金会（MJFF）建立合作 |
PD, MSA, DLB |
|
|||||
| SST002 PET tracer |
Undisclosed |
|
|||||
| SSA001 Novel Biomarker |
Undisclosed |
|
|||||
| SSA002 Novel Biomarker |
Undisclosed |
|
|||||
| Candidate SST001/FD4 α-Syn PET tracer 与迈克尔·J·福克斯基金会（MJFF）建立合作 |
|||||
|---|---|---|---|---|---|
| IndicationPD, MSA, DLB | |||||
| Early Discovery | Pre-clinical | IND | Phase I | Phase II | Phase III |
|
|
|||||
| Candidate SST002 PET tracer |
|||||
|---|---|---|---|---|---|
| IndicationUndisclosed | |||||
| Early Discovery | Pre-clinical | IND | Phase I | Phase II | Phase III |
|
|
|||||
| Candidate SSA001 Novel Biomarker |
|||||
|---|---|---|---|---|---|
| IndicationUndisclosed | |||||
| Early Discovery | Pre-clinical | IND | Phase I | Phase II | Phase III |
|
|
|||||
| Candidate SSA002 Novel Biomarker |
|||||
|---|---|---|---|---|---|
| IndicationUndisclosed | |||||
| Early Discovery | Pre-clinical | IND | Phase I | Phase II | Phase III |
|
|
|||||